Moderna, Inc. 4

Moderna CFO James M. Mock had 11,797 RSUs vest into common stock and 5,704 shares withheld for taxes on September 4, 2026.

On September 4, 2026, Moderna, Inc. Chief Financial Officer James M. Mock had 11,797 restricted stock units convert into an equivalent number of common shares, increasing his direct common stock holdings to 80,079 shares. In connection with this vesting, 5,704 shares of common stock were withheld by the company at a price of $148.87 per share to satisfy tax withholding obligations, representing an estimated $849,640 in value. The RSU vesting is part of a previously disclosed award, with 25% having vested on December 5, 2025 and the balance vesting in equal quarterly installments thereafter, indicating a routine equity compensation event rather than an open‑market purchase or discretionary sale.

Filing Facts

CIK

1682852

Ticker

MRNA

Form

4

Source Type

fda

Accession

0001682852-26-000172

Alert Tier

7